title: Inhaled iloprost for the treatment of Raynaud's phenomenon.
authors.forename: A
authors.initials: A
authors.lastname: Pakozdi
authors.forename: K
authors.initials: K
authors.lastname: Howell
authors.forename: H
authors.initials: H
authors.lastname: Wilson
authors.forename: S
authors.initials: S
authors.lastname: Fox
authors.forename: L
authors.initials: L
authors.lastname: Gonzalez
authors.forename: C M
authors.initials: CM
authors.lastname: Black
authors.forename: C P
authors.initials: CP
authors.lastname: Denton
mesh_terms: D000280:Administration, Inhalation; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D016285:Iloprost / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011928:Raynaud Disease / Q000150:complications / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000150:complications; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D014665:Vasodilator Agents; D016285:Iloprost